PXLW Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. Despite a slightly improving MACD, PXLW is still in a broader bearish trend (SMA_200 > SMA_20 > SMA_5), insiders are accelerating sales, and fundamentals are deteriorating (2025/Q3 revenue and EPS down YoY). With no Intellectia buy signals and very unstable/illiquid options positioning, the setup does not favor an impatient buyer looking for immediate upside.
Price/Trend: PXLW is trading at 6.465 (-2.65% regular session; -3.24% pre-market), below the pivot (6.636), consistent with near-term weakness. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), implying the primary trend remains down. Momentum: MACD histogram is slightly positive (0.00438) and expanding, suggesting a mild short-term attempt to stabilize/bounce, but it is not strong enough to override the bearish MA structure. RSI(6)=59.33 is neutral-to-slightly bullish, not an oversold “snapback” condition. Levels: Support S1=6.243 then S2=6.00; resistance R1=7.03 then R2=7.273. With price below pivot, risk of a support test is elevated. Pattern-based odds: Similar-pattern stats indicate muted forward returns (next day ~0.76% upside probability 30%; next week/month slightly negative), which does not support an urgent buy.
Intellectia Proprietary Trading Signals
holds and price reclaims the 6.636 pivot, opening a path toward 7.03 (R1).
and price trading below pivot.
Latest reported quarter: 2025/Q3 (seasonal quarter). Growth/profitability trend: Revenue fell to $8.77M (-7.94% YoY). Net income was -$4.43M (loss widened; -45.56% YoY). EPS was -0.81 (-51.20% YoY). Gross margin was 49.83% (-2.69% YoY). Takeaway: Top-line contraction plus worsening losses and slightly lower margin point to weakening operating momentum, which does not support an aggressive buy-right-now stance.
Recent change: On 2025-11-11, Roth Capital (Suji Desilva) lowered the price target to $12 from $15 but maintained a Buy rating. Rationale cited: seasonal Q3, guidance retracted due to pending close of Shanghai subsidiary sale, plus related funding/divestiture events. Wall Street-style pros: Maintained Buy suggests perceived longer-term upside potential and strategic actions (divestiture/funding) could improve focus/capitalization. Cons: Price target cut signals reduced confidence/near-term headwinds; guidance retraction and business transition increase uncertainty. Combined with insider selling and weak YoY financial trends, the “pro” case is not strong enough for an impatient entry. Influential/political trading: No recent congress trading data available (no signal from politicians in the last 90 days).
